Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
88 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Calgary - Foothills Medical Centre
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Vancouver General Hospital
Vancouver, British Columbia, Canada
- Hamilton General Hospital
Hamilton, Ontario, Canada
- Ottawa Hospital Research Institute
Ottawa, Ontario, Canada
- St. Michaels Hospital
Toronto, Ontario, Canada
- Sunnybrook Health Sciences Center
Toronto, Ontario, Canada
- University of Montreal Hospital
Montreal, Quebec, Canada
- University Hospital Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
- Clinic Frankfurt Hoechst
Frankfurt am Main, Hesse, Germany
- University Hospital Augsburg
Augsburg, Germany
- Charite University Medicine Berlin
Berlin, Germany
- University Hospital Tuebingen
Tübingen, Germany
- National Cerebral and Cardiovascular Center
Suita, Osaka, Japan
- Kyushu Medical Center
Fukuoka, Japan
- Gifu University Hospital
Gifu, Japan
- Kagoshima City Hospital
Kagoshima, Japan
- Kobe City Medical Center General Hospital
Kobe, Japan
- Japanese Red Cross Kyoto Daini Hospital
Kyoto, Japan
- Iwate Prefectural Central Hospital
Morioka, Japan
- Niigata City General Hospital
Niigata, Japan
- Kmu University Hospital
Osaka, Japan
- Nho Osaka National Hospital
Osaka, Japan
- Nakamura Memorial Hospital
Sapporo, Japan
- Jichi Medical University Hospital
Shimotsuke, Japan
- Kyorin University Hospital
Tokyo, Japan
- Toranomon Hospital
Tokyo, Japan
- Hospital Universitari Germans Trias I Pujol
Badalona, Barcelona, Spain
- Vall D'Hebron University Hospital (vhuh)
Horta, Barcelona, Spain
- Bellvitge University Hospital,
L'Hospitalet de Llobregat, Barcelona, Spain
- Santa Creu and Sant Pau Hospital
Barcelona, Catalonia, Spain
- Girona University Hospital
Girona, Catalonia, Spain
- Arnau de Vilanova University Hospital
Lleida, Catalonia, Spain
- John Radcliffe Hospital
Oxford, Oxfordshire, United Kingdom
- Royal Stoke University Hospital
Stoke-on-Trent, Staffordshire, United Kingdom
- Royal Victoria Infirmary
Newcastle upon Tyne, United Kingdom
- Queens Medical Centre
Nottingham, United Kingdom
- University of Alabama Hospital
Birmingham, Alabama, United States
- St. Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Kaiser Permanente Baldwin Park Medical Center
Baldwin Park, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Dec 2021
- Primary completion
- 1 Jan 2028
- Completion
- 1 Jan 2028
- Last update posted
- 21 Jan 2026
- Registered enrollment
- 860
- Registry id
- NCT03496883
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.